FY25 Half Year Results
| Stock | Integrated Research Ltd (IRI.ASX) |
|---|---|
| Release Time | 20 Feb 2025, 8:48 a.m. |
| Price Sensitive | Yes |
Integrated Research Ltd Reports FY25 Half Year Results
- New business growth of 76% to $7.6m versus prior corresponding period
- TCV and statutory revenue down 36% and 29% respectively due to softer 1H renewals book
- EBITDA down 58% on prior corresponding period to $4.6m
Integrated Research Ltd, a leading global provider of technology that harvests and analyses data to help enterprise clients optimise their IT ecosystem, has released its results for the six-month period ending 31 December 2024. The company reported new business growth of 76% to $7.6m versus the prior corresponding period, but TCV (Total Contract Value) and statutory revenue were down 36% to $26.5m and 29% to $28.8m respectively due to a softer 1H renewals book. EBITDA decreased by 58% on the prior corresponding period to $4.6 million, and Net Profit After Tax (NPAT) decreased by 59% to $4.6 million. However, pro forma revenue was steady, decreasing by only 2%, and pro forma EBITDA was up 53% to $11.8 million, which included gains from currency exchange and the sale of non-core business. The company is focused on executing its product-led growth strategy, with priorities including investing in innovation to create and commercialise new products, growing the sales pipeline and revenue contribution from new business, and transitioning to sustainable growth less reliant on contract renewals.
The company expects to make further new product announcements in coming months.
The company is focused on executing its product-led growth strategy, with priorities including investing in innovation to create and commercialise new products, growing the sales pipeline and revenue contribution from new business, and transitioning to sustainable growth less reliant on contract renewals.